9-4118585-G-T

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_001042413.2(GLIS3):​c.893C>A​(p.Ser298Tyr) variant causes a missense change. The variant allele was found at a frequency of 0.00257 in 1,614,242 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 12 hom. )

Consequence

GLIS3
NM_001042413.2 missense

Scores

3
7
8

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 4.37

Publications

12 publications found
Variant links:
Genes affected
GLIS3 (HGNC:28510): (GLIS family zinc finger 3) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]
GLIS3 Gene-Disease associations (from GenCC):
  • neonatal diabetes mellitus with congenital hypothyroidism
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Tourette syndrome
    Inheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.012983769).
BP6
Variant 9-4118585-G-T is Benign according to our data. Variant chr9-4118585-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 366989.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High Homozygotes in GnomAdExome4 at 12 AR,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GLIS3NM_001042413.2 linkc.893C>A p.Ser298Tyr missense_variant Exon 4 of 11 ENST00000381971.8 NP_001035878.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GLIS3ENST00000381971.8 linkc.893C>A p.Ser298Tyr missense_variant Exon 4 of 11 5 NM_001042413.2 ENSP00000371398.3

Frequencies

GnomAD3 genomes
AF:
0.00192
AC:
292
AN:
152232
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000579
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00111
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00207
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00315
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00215
AC:
540
AN:
251494
AF XY:
0.00210
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.00312
Gnomad ASJ exome
AF:
0.00198
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00148
Gnomad NFE exome
AF:
0.00309
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00264
AC:
3859
AN:
1461892
Hom.:
12
Cov.:
36
AF XY:
0.00256
AC XY:
1860
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33480
American (AMR)
AF:
0.00311
AC:
139
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00249
AC:
65
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.0000116
AC:
1
AN:
86258
European-Finnish (FIN)
AF:
0.00154
AC:
82
AN:
53420
Middle Eastern (MID)
AF:
0.00156
AC:
9
AN:
5768
European-Non Finnish (NFE)
AF:
0.00306
AC:
3402
AN:
1112010
Other (OTH)
AF:
0.00248
AC:
150
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
264
527
791
1054
1318
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00192
AC:
292
AN:
152350
Hom.:
1
Cov.:
32
AF XY:
0.00184
AC XY:
137
AN XY:
74510
show subpopulations
African (AFR)
AF:
0.000577
AC:
24
AN:
41586
American (AMR)
AF:
0.00111
AC:
17
AN:
15304
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00207
AC:
22
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00315
AC:
214
AN:
68034
Other (OTH)
AF:
0.00142
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
15
30
46
61
76
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00291
Hom.:
5
Bravo
AF:
0.00208
TwinsUK
AF:
0.00297
AC:
11
ALSPAC
AF:
0.00311
AC:
12
ESP6500AA
AF:
0.00136
AC:
6
ESP6500EA
AF:
0.00326
AC:
28
ExAC
AF:
0.00201
AC:
244

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Jan 24, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Jul 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GLIS3: BS2

Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics, Academic Medical Center
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not specified Benign:1
Jun 21, 2018
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Monogenic diabetes Benign:1
Jun 01, 2018
Personalized Diabetes Medicine Program, University of Maryland School of Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

ACMG criteria: BS1 (3 homozygotes in gnomAD), BS2 (38 cases and 46 controls in type2diabetesgenetics.org) [PP3 (6 predictors), BP4 (4 predictors) but Revel score 0.179: conflicting evidence, not using]= benign

Neonatal diabetes mellitus with congenital hypothyroidism Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

GLIS3-related disorder Benign:1
Oct 19, 2022
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.40
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.25
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Benign
0.33
T;.
Eigen
Pathogenic
0.77
Eigen_PC
Pathogenic
0.73
FATHMM_MKL
Pathogenic
0.97
D
LIST_S2
Uncertain
0.91
D;D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.013
T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Uncertain
2.3
M;.
PhyloP100
4.4
PrimateAI
Uncertain
0.61
T
PROVEAN
Uncertain
-2.4
N;N
REVEL
Benign
0.18
Sift
Uncertain
0.0050
D;D
Sift4G
Benign
0.063
T;D
Vest4
0.53
ClinPred
0.049
T
GERP RS
5.6
Varity_R
0.31
gMVP
0.43
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148572278; hg19: chr9-4118585; COSMIC: COSV106102246; COSMIC: COSV106102246; API